Glenmark Pharmaceuticals Ltd 2025 Integrated Report
Company: Glenmark Pharmaceuticals Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Integrated Report
Pages: 412
The report presents Glenmark 3.0 as a focused, global, innovation-led transformation. It highlights consolidated FY 2025 revenue of INR 133 Bn, 12.8% year-on-year growth, and continued expansion of branded markets. Sustainability highlights include SBTi-validated climate goals, water positivity across India operations, and achievement of the zero waste to landfill target ahead of schedule.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.